Bupropion Sustained released versus Placebo for seasonal affective Disorder
Journal: Archives of Depression and Anxiety (Vol.3, No. 1)Publication Date: 2017-12-13
Authors : Martin H Teicher Danielle M Webster; Steven B Lowen;
Page : 009-013
Keywords : SAD; Winter depression; Bupropion; Gender differences;
Abstract
Background: The majority of seasonal affective disorder (SAD) studies have evaluated the use of light or selective serotonin reuptake inhibitors (SSRI). The purpose of the present study was to evaluate bupropion sustained-released (SR), a non-SSRI antidepressant, for the treatment of SAD.
Other Latest Articles
- Association between Cannabis use, Depression and Apathy: A Study of an Internet Community Sample of Young Adults
- Labor Epidural Analgesia and Postpartum Depression
- Depression, Alcoholism, and Genetic Alcohol Sensitivity Regulated by ALDH2 and ADH1B Polymorphisms among Japanese Community-Dwelling Adults
- EFFECT OF FIRST LOW WAGES’ JOB ON THE SELF-ESTEEM OF PAKISTANI MIDDLE-CLASS FRESH GRADUATES
- Electrophysiological Profiling of Depression in the Elderly
Last modified: 2018-09-14 15:22:57